We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to Colgate-Palmolive (CL) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Read MoreHide Full Article
Wall Street analysts forecast that Colgate-Palmolive (CL - Free Report) will report quarterly earnings of $0.89 per share in its upcoming release, pointing to a year-over-year decline of 2.2%. It is anticipated that revenues will amount to $5.06 billion, exhibiting no change compared to compared to the year-ago quarter.
The consensus EPS estimate for the quarter has undergone an upward revision of 0.2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain Colgate-Palmolive metrics that are commonly tracked and forecasted by Wall Street analysts.
The consensus estimate for 'Net Sales- Pet Nutrition' stands at $1.13 billion. The estimate indicates a change of +1.1% from the prior-year quarter.
Analysts forecast 'Net Sales- Total Oral, Personal and Home Care' to reach $3.91 billion. The estimate indicates a year-over-year change of -0.9%.
Analysts' assessment points toward 'Net Sales- Oral, Personal and Home Care- North America' reaching $1.01 billion. The estimate points to a change of +1% from the year-ago quarter.
According to the collective judgment of analysts, 'Net Sales- Oral, Personal and Home Care- Latin America' should come in at $1.24 billion. The estimate points to a change of -2.5% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Net Sales- Oral, Personal and Home Care- Africa/Eurasia' of $277.30 million. The estimate indicates a change of +1.6% from the prior-year quarter.
Analysts predict that the 'Net Sales- Oral, Personal and Home Care- Europe' will reach $716.03 million. The estimate indicates a year-over-year change of -0.6%.
The consensus among analysts is that 'Net Sales- Oral, Personal and Home Care- Asia Pacific' will reach $666.60 million. The estimate points to a change of -2.3% from the year-ago quarter.
Based on the collective assessment of analysts, 'Operating profit- Total Oral, Personal and Home Care' should arrive at $999.32 million. Compared to the current estimate, the company reported $1.06 billion in the same quarter of the previous year.
The combined assessment of analysts suggests that 'Operating profit- Pet Nutrition' will likely reach $260.59 million. Compared to the present estimate, the company reported $235.00 million in the same quarter last year.
Analysts expect 'Operating profit- Oral, Personal and Home Care- North America' to come in at $200.45 million. The estimate compares to the year-ago value of $223.00 million.
It is projected by analysts that the 'Operating profit- Oral, Personal and Home Care- Latin America' will reach $364.91 million. Compared to the current estimate, the company reported $417.00 million in the same quarter of the previous year.
The average prediction of analysts places 'Operating profit- Oral, Personal and Home Care- Africa/Eurasia' at $61.54 million. Compared to the present estimate, the company reported $64.00 million in the same quarter last year.
Shares of Colgate-Palmolive have experienced a change of -4.9% in the past month compared to the +3.6% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), CL is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Countdown to Colgate-Palmolive (CL) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Wall Street analysts forecast that Colgate-Palmolive (CL - Free Report) will report quarterly earnings of $0.89 per share in its upcoming release, pointing to a year-over-year decline of 2.2%. It is anticipated that revenues will amount to $5.06 billion, exhibiting no change compared to compared to the year-ago quarter.
The consensus EPS estimate for the quarter has undergone an upward revision of 0.2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain Colgate-Palmolive metrics that are commonly tracked and forecasted by Wall Street analysts.
The consensus estimate for 'Net Sales- Pet Nutrition' stands at $1.13 billion. The estimate indicates a change of +1.1% from the prior-year quarter.
Analysts forecast 'Net Sales- Total Oral, Personal and Home Care' to reach $3.91 billion. The estimate indicates a year-over-year change of -0.9%.
Analysts' assessment points toward 'Net Sales- Oral, Personal and Home Care- North America' reaching $1.01 billion. The estimate points to a change of +1% from the year-ago quarter.
According to the collective judgment of analysts, 'Net Sales- Oral, Personal and Home Care- Latin America' should come in at $1.24 billion. The estimate points to a change of -2.5% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Net Sales- Oral, Personal and Home Care- Africa/Eurasia' of $277.30 million. The estimate indicates a change of +1.6% from the prior-year quarter.
Analysts predict that the 'Net Sales- Oral, Personal and Home Care- Europe' will reach $716.03 million. The estimate indicates a year-over-year change of -0.6%.
The consensus among analysts is that 'Net Sales- Oral, Personal and Home Care- Asia Pacific' will reach $666.60 million. The estimate points to a change of -2.3% from the year-ago quarter.
Based on the collective assessment of analysts, 'Operating profit- Total Oral, Personal and Home Care' should arrive at $999.32 million. Compared to the current estimate, the company reported $1.06 billion in the same quarter of the previous year.
The combined assessment of analysts suggests that 'Operating profit- Pet Nutrition' will likely reach $260.59 million. Compared to the present estimate, the company reported $235.00 million in the same quarter last year.
Analysts expect 'Operating profit- Oral, Personal and Home Care- North America' to come in at $200.45 million. The estimate compares to the year-ago value of $223.00 million.
It is projected by analysts that the 'Operating profit- Oral, Personal and Home Care- Latin America' will reach $364.91 million. Compared to the current estimate, the company reported $417.00 million in the same quarter of the previous year.
The average prediction of analysts places 'Operating profit- Oral, Personal and Home Care- Africa/Eurasia' at $61.54 million. Compared to the present estimate, the company reported $64.00 million in the same quarter last year.
View all Key Company Metrics for Colgate-Palmolive here>>>Shares of Colgate-Palmolive have experienced a change of -4.9% in the past month compared to the +3.6% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), CL is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .